External broker reports(aggregated public sources), Axis Direct

Axis Direct

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only.  Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

Navin Fluorine International / Equity Bottom-Up

<ul><li>We are revising our estimates downward due to a slower-than-expected recovery in the Specialty Chemicals.</li><li>While we believe the longterm growth prospects remain strong, the growth is likely to pick up towards the end of FY25, subject to project stabilization and optimal capacity utilization.</li><li>We value the stock at 27x FY26E, with a TP of Rs 3,135/share, which implies a downside of 17% from the CMP.</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

We are revising our estimates downward due to a slower-than-expected recovery in the Specialty Chemicals.While we believe the longterm growth prospects remain strong, the growth is likely to pick up towards the end of FY25, subject to project stabilization and optimal capacity utilization.We value the stock at 27x FY26E, with a TP of Rs 3,135/share, which implies a downside of 17% from the CMP.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Navin Fluorine International Ltd. - Specialty Chemicals Headwinds Continue